Literature DB >> 26839072

High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome.

A Monteagudo-Mera1, J C Arthur2, C Jobin2,3, T Keku2, J M Bruno-Barcena4, M A Azcarate-Peril1,5.   

Abstract

Prebiotics are selectively fermented ingredients that result in specific changes in the composition and/or activity of the gastrointestinal microbiota, thus conferring benefit(s) upon the host health. The aim of this study was to evaluate the influence of a β(1-4)galacto-oligosaccharides (GOS) formulation consisting of 90% pure GOS (GOS90), on the composition and activity of the mouse gut microbiota. Germ-free mice were colonised with microbiota from four pathogen-free wt 129 mice donors (SPF), and stools were collected during a feeding trial in which GOS90 was delivered orally for 14 days. Pyrosequencing of 16S rDNA amplicons showed that Bifidobacterium and specific Lactobacillus, Bacteroides and Clostridiales were more prevalent in GOS90-fed mice after 14 days, although the prebiotic impact on Bifidobacterium varied among individual mice. Prebiotic feeding also resulted in decreased abundance of Bacteroidales, Helicobacter and Clostridium. High-throughput quantitative PCR showed an increased abundance of Bifidobacterium adolescentis, Bifidobacterium pseudocatenulatum, Bifidobacterium lactis and Bifidobacterium gallicum in the prebiotic-fed mice. Control female mice showed a higher diversity (phylogenetic diversity (PD) = 15.1 ± 3.4 in stools and PD = 13.0 ± 0.6 in intestinal contents) than control males (PD = 7.8 ± 1.6 in stool samples and PD = 9.5 ± 1.0 in intestinal contents). GOS90 did not modify inflammatory biomarkers (interleukin (IL)-6, IL-12, IL-1β, interferon gamma and tumour necrosis factor alpha). Decreased butyrate, acetate and lactate concentrations in stools of prebiotic fed mice suggested an increase in colonic absorption and reduced excretion. Overall, our results demonstrate that GOS90 is capable of modulating the intestinal microbiome resulting in expansion of the probiome (autochtonous commensal intestinal bacteria considered to have a beneficial influence on health).

Entities:  

Keywords:  Bifidobacterium; mouse gut microbiome; prebiotics

Mesh:

Substances:

Year:  2016        PMID: 26839072      PMCID: PMC4974821          DOI: 10.3920/BM2015.0114

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  84 in total

1.  A novel galactooligosaccharide mixture increases the bifidobacterial population numbers in a continuous in vitro fermentation system and in the proximal colonic contents of pigs in vivo.

Authors:  George Tzortzis; Athanasios K Goulas; Jennifer M Gee; Glenn R Gibson
Journal:  J Nutr       Date:  2005-07       Impact factor: 4.798

2.  A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice.

Authors:  Laura E J Searle; Angus Best; Alejandro Nunez; Francisco J Salguero; Linda Johnson; Ute Weyer; Alexandra H Dugdale; William A Cooley; Ben Carter; Gareth Jones; George Tzortzis; Martin J Woodward; Roberto M La Ragione
Journal:  J Med Microbiol       Date:  2009-01       Impact factor: 2.472

3.  Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity.

Authors:  Janet G M Markle; Daniel N Frank; Steven Mortin-Toth; Charles E Robertson; Leah M Feazel; Ulrike Rolle-Kampczyk; Martin von Bergen; Kathy D McCoy; Andrew J Macpherson; Jayne S Danska
Journal:  Science       Date:  2013-01-17       Impact factor: 47.728

4.  Selective carbohydrate utilization by lactobacilli and bifidobacteria.

Authors:  D Watson; M O'Connell Motherway; M H C Schoterman; R J Joost van Neerven; A Nauta; D van Sinderen
Journal:  J Appl Microbiol       Date:  2013-01-11       Impact factor: 3.772

Review 5.  The role of the gastrointestinal microbiota in colorectal cancer.

Authors:  Ian R Rowland
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

6.  Influence of coffee (Coffea arabica) and galacto-oligosaccharide consumption on intestinal microbiota and the host responses.

Authors:  Tatsuya Nakayama; Kazunori Oishi
Journal:  FEMS Microbiol Lett       Date:  2013-05-09       Impact factor: 2.742

7.  Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome.

Authors:  Christina L Ohland; Lisa Kish; Haley Bell; Aducio Thiesen; Naomi Hotte; Evelina Pankiv; Karen L Madsen
Journal:  Psychoneuroendocrinology       Date:  2013-04-06       Impact factor: 4.905

8.  A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults.

Authors:  Jelena Vulevic; Aleksandra Juric; George Tzortzis; Glenn R Gibson
Journal:  J Nutr       Date:  2013-01-09       Impact factor: 4.798

9.  SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor.

Authors:  Marco A R Vinolo; G John Ferguson; Suhasini Kulkarni; George Damoulakis; Karen Anderson; Mohammad Bohlooly-Y; Len Stephens; Phillip T Hawkins; Rui Curi
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

10.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

View more
  25 in total

1.  Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals.

Authors:  M Andrea Azcarate-Peril; Andrew J Ritter; Dennis Savaiano; Andrea Monteagudo-Mera; Carlton Anderson; Scott T Magness; Todd R Klaenhammer
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

2.  Development of immune and microbial environments is independently regulated in the mammary gland.

Authors:  K Niimi; K Usami; Y Fujita; M Abe; M Furukawa; Y Suyama; Y Sakai; M Kamioka; N Shibata; E J Park; S Sato; H Kiyono; H Yoneyama; H Kitazawa; K Watanabe; T Nochi; H Aso
Journal:  Mucosal Immunol       Date:  2017-12-20       Impact factor: 7.313

3.  Galactooligosaccharide supplementation provides protection against Citrobacter rodentium-induced colitis without limiting pathogen burden.

Authors:  Hatem Kittana; Maria I Quintero-Villegas; Laure B Bindels; João Carlos Gomes-Neto; Robert J Schmaltz; Rafael R Segura Munoz; Liz A Cody; Rodney A Moxley; Jesse Hostetter; Robert W Hutkins; Amanda E Ramer-Tait
Journal:  Microbiology       Date:  2017-12-19       Impact factor: 2.777

4.  An Attenuated Salmonella enterica Serovar Typhimurium Strain and Galacto-Oligosaccharides Accelerate Clearance of Salmonella Infections in Poultry through Modifications to the Gut Microbiome.

Authors:  M Andrea Azcarate-Peril; Natasha Butz; Maria Belen Cadenas; Matthew Koci; Anne Ballou; Mary Mendoza; Rizwana Ali; Hosni Hassan
Journal:  Appl Environ Microbiol       Date:  2018-02-14       Impact factor: 4.792

Review 5.  Emerging Technologies for Gut Microbiome Research.

Authors:  Jason W Arnold; Jeffrey Roach; M Andrea Azcarate-Peril
Journal:  Trends Microbiol       Date:  2016-07-15       Impact factor: 17.079

6.  Dietary Prebiotics and Bioactive Milk Fractions Improve NREM Sleep, Enhance REM Sleep Rebound and Attenuate the Stress-Induced Decrease in Diurnal Temperature and Gut Microbial Alpha Diversity.

Authors:  Robert S Thompson; Rachel Roller; Agnieszka Mika; Benjamin N Greenwood; Rob Knight; Maciej Chichlowski; Brian M Berg; Monika Fleshner
Journal:  Front Behav Neurosci       Date:  2017-01-10       Impact factor: 3.558

7.  Biochemical Characterization of the Functional Roles of Residues in the Active Site of the β-Galactosidase from Bacillus circulans ATCC 31382.

Authors:  Huifang Yin; Tjaard Pijning; Xiangfeng Meng; Lubbert Dijkhuizen; Sander S van Leeuwen
Journal:  Biochemistry       Date:  2017-06-05       Impact factor: 3.162

8.  Engineering of the Bacillus circulans β-Galactosidase Product Specificity.

Authors:  Huifang Yin; Tjaard Pijning; Xiangfeng Meng; Lubbert Dijkhuizen; Sander S van Leeuwen
Journal:  Biochemistry       Date:  2017-01-25       Impact factor: 3.162

9.  A comparison of sequencing platforms and bioinformatics pipelines for compositional analysis of the gut microbiome.

Authors:  Imane Allali; Jason W Arnold; Jeffrey Roach; Maria Belen Cadenas; Natasha Butz; Hosni M Hassan; Matthew Koci; Anne Ballou; Mary Mendoza; Rizwana Ali; M Andrea Azcarate-Peril
Journal:  BMC Microbiol       Date:  2017-09-13       Impact factor: 3.605

Review 10.  Microbiome effects on immunity, health and disease in the lung.

Authors:  Shakti D Shukla; Kurtis F Budden; Rachael Neal; Philip M Hansbro
Journal:  Clin Transl Immunology       Date:  2017-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.